Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023. Bloomberg | Bloomberg | Getty Images Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals on Tuesday, after the company raised its full-year guidance following better-than-expected first-quarter results. Stock pared gains … Read more